Literature DB >> 25645778

Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.

M A Varona1, A Soriano2, A Aguirre-Jaime3, S Garrido4, E Oton5, D Diaz5, J Portero6, P Bravo7, M A Barrera2, A Perera8.   

Abstract

BACKGROUND: Recurrence of hepatocellular carcinoma (HCC) and cirrhosis after a liver transplantation (LT) is a major concern, and a strict Milan criteria selection of candidates does not accurately discriminate the relapse rate after LT.
PURPOSE: This study sought to analyze the risk factors affecting tumor recurrence after LT for related cirrhosis HCC and the application of the French prognostic model (preLT alpha-fetoprotein [AFP], size, number) in a single center.
METHODS: In a retrospective observational study of LT for HCC and cirrhosis, clinicopathological features were analyzed. Also, the preoperative and postoperative AFP model score was calculated with a cutoff of 2.
RESULTS: Of 480, 109 patients underwent cadaveric LT for HCC. Eight of them had a relapse (7%). High AFP level, AFP model score >2, high pathological tumor-node-metastasis (pTNM) stage, poor differentiation, macrovascular-microvascular invasion, infiltration, and R1 margin were statistically significant (P < .05) for recurrence. Also, in the preoperative model, AFP score >2 was a predictor of worse survival (1-, 3-, 5-, 10-year survival of 81%, 51%, 30%, 30% vs 90%, 76%, 73%, 69% in ≤2, with P = .005). Regarding the postoperative model, similar results were found (1-, 3-, 5-, 10-year survival of 84%, 47%, 37%, 37% vs 90%, 78%, 73%, 52%, P = .028) between AFP model score >2 and ≤2, respectively. However, Milan and up-to-7 criteria were not accurate in recurrence nor in survival.
CONCLUSIONS: The French AFP model has proven to be a more discerning prognostic tool than other established criteria in the prediction of recurrence and survival. Also, in postoperative prognosis, pathological risk factors for relapse such as pTNM, differentiation grade, macrovascular-microvascular invasion, infiltration, and R1 margin have been predictors of recurrence.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645778     DOI: 10.1016/j.transproceed.2014.12.013

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  21 in total

Review 1.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.

Authors:  Bérénice Charrière; Charlotte Maulat; Bertrand Suc; Fabrice Muscari
Journal:  World J Hepatol       Date:  2016-07-28

3.  Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  A Bauschke; A Altendorf-Hofmann; H Kissler; A Koch; C Malessa; U Settmacher
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-28       Impact factor: 4.553

Review 4.  Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future.

Authors:  Arturo Soriano; Aranzazu Varona; Rajesh Gianchandani; Modesto Enrique Moneva; Javier Arranz; Antonio Gonzalez; Manuel Barrera
Journal:  World J Hepatol       Date:  2016-01-08

Review 5.  Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation.

Authors:  Li-Ying Wang; Shu-Sen Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2018-07       Impact factor: 3.066

Review 6.  Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation.

Authors:  Helena Degroote; Anja Geerts; Xavier Verhelst; Hans Van Vlierberghe
Journal:  Cancers (Basel)       Date:  2022-06-16       Impact factor: 6.575

7.  Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: single center experience from Southern Taiwan.

Authors:  Mahmoud Abdelwahab Ali; Wei-Feng Li; Jing-Houng Wang; Chih-Che Lin; Ying-Ju Chen; Ting-Lung Lin; Tsan-Shiun Lin; Sheng-Nan Lu; Chih-Chi Wang; Chao-Long Chen
Journal:  HPB (Oxford)       Date:  2016-08-25       Impact factor: 3.647

Review 8.  Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Yves Dittmar; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Late recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Julia A Zhang; Sandi A Kwee; Linda L Wong
Journal:  Hepatoma Res       Date:  2017-04-10

10.  Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Leonardo Lorente; Sergio T Rodriguez; Pablo Sanz; Pedro Abreu-González; Dácil Díaz; Antonia M Moreno; Elisa Borja; María M Martín; Alejandro Jiménez; Manuel A Barrera
Journal:  Int J Mol Sci       Date:  2016-04-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.